Reproductive

Uterine Fibroids (Leiomyomas)

Also known as:
Uterine Fibroids (Leiomyomas)
Leiomyoma
Myoma

Uterine Fibroids (Leiomyomas) is are benign smooth muscle tumors of the uterus that affect up to 70-80% of women by age 50. They are the most common pelvic tumor in women and a leading cause of heavy menstrual bleeding, pelvic pressure, and reproductive dysfunction. It is characterized by benign monoclonal tumors - no malignant potential (0.1% transform to leiomyosarcoma), estrogen and progesterone dependent - grow during reproductive years, shrink after menopause, multiple fibroids in 2/3 of affected women. At Healers Clinic, our integrative approach combines evidence-based conventional medicine with homeopathy, ayurveda, and physiotherapy to address the root causes using our "Cure from the Core" philosophy. Our team of Dr. Hafeel Ambalath & Dr. Saya Pareeth and 25+ practitioners have helped 15,000+ patients find lasting relief. Book a consultation to explore how we can help you.

N99

ICD-10

Individual results vary

Success Rate

Varies by condition severity

Duration

15,000+

Patients

General Consultation
Holistic Consult
Homeopathic Consultation
Ayurvedic Consultation

At a Glance

Severity

_symptomatic vs asymptomatic; size

Prevalence

Most common benign pelvic tumor in women. Affects 70-80% of women by age 50. Higher prevalence in obese women (2-3x) and lower in smokers (paradoxically).

Success Rate

Individual results vary

Patients

15,000+

Related Conditions

Adenomyosis
Ovarian tumors
Endometrial cancer

Treatment Options

General Consultation
Holistic Consult
Homeopathic Consultation
Ayurvedic Consultation
View All Treatments

Contact Us

+971562741787
Mon-Sat: 9am-9pm
WhatsApp Us
reproductive
_symptomatic vs asymptomatic; size
Most common benign pelvic tumor in women. Affects 70-80% of women by age 50. Higher prevalence in obese women (2-3x) and lower in smokers (paradoxically).
Recently updated

Uterine Fibroids (Leiomyomas)

Also known as:Uterine Fibroids (Leiomyomas), Leiomyoma, Myoma, Fibromyoma
ICD-10
N99
Uterine Fibroids (Leiomyomas)
ICD-11
N99
Uterine Fibroids (Leiomyomas)
Success Rate
Individual results vary
Patients
15,000+
Duration
Varies by condition severity
Read Time
5 min
0 words
Typical Improvement Timeline
Varies by condition and individual
Our Treatment Services
General Consultation
Holistic Consult
Homeopathic Consultation
Ayurvedic Consultation
NLS Screening
Related Conditions
Adenomyosis
Ovarian tumors
Endometrial cancer
Healers Clinic Medical Team

What is Uterine Fibroids (Leiomyomas)?

Etymology

Word Origin

Uterine Fibroids (Leiomyomas) is a medical term derived from standard medical nomenclature used to describe Fibroids are non-cancerous growths in the muscular wall of the uterus. They range from tiny seedlings to large masses that distort and enlarge the uterus. Estrogen and progesterone promote their growth. Many fibroids shrink after menopause when estrogen levels drop..

Historical Context

The terminology for Uterine Fibroids (Leiomyomas) has evolved through centuries of medical advancement. Initially described based on observable symptoms, modern medicine has refined the definition to encompass specific pathophysiological mechanisms and diagnostic criteria. Today, Uterine Fibroids (Leiomyomas) is recognized as FIGO Classification: Type 0 (pedunculated intracavitary), Type 1 (<50% intramural), Type 2 (≥50% intramural), Type 3 (100% intramural, touching endometrium), Type 4 (intramural only), Type 5 (≥50% subserosal), Type 6 (<50% subserosal), Type 7 (subserosal pedunculated), Type 8 (non-uterine)..

Cross-Cultural Terms

  • Arabic: The local term for Uterine Fibroids (Leiomyomas) in Arabic medical contexts
  • Hindi/Urdu: The local term for Uterine Fibroids (Leiomyomas) in Hindi/Urdu medical contexts
  • Chinese: The local term for Uterine Fibroids (Leiomyomas) in Chinese medical contexts
  • French: The local term for Uterine Fibroids (Leiomyomas) in French medical contexts
  • German: The local term for Uterine Fibroids (Leiomyomas) in German medical contexts
  • Spanish: The local term for Uterine Fibroids (Leiomyomas) in Spanish medical contexts

Medical Terminology

Synonyms

FibroidsMyomasUterine myomasBenign uterine tumorsuterine-fibroids-(leiomyomas)uterine fibroids (leiomyomas)Uterine Fibroids (Leiomyomas)

Abbreviations

  • UF(
  • FCT0(IT1(IT2(IT3(ITET4(OT5(ST6(ST7(PT8(

Common Names

Common Names

  • Fibroids
  • Myomas
  • Uterine myomas
  • Benign uterine tumors
  • Uterine Fibroids (Leiomyomas)

Regional Variations

  • Uterine Fibroids (Leiomyomas) (UAE/Gulf)
  • Uterine Fibroids (Leiomyomas) (India/South Asia)
  • FIGO Classification: Type 0 (pedunculated intracavitary), Type 1 (<50% intramural), Type 2 (≥50% intramural), Type 3 (100% intramural, touching endometrium), Type 4 (intramural only), Type 5 (≥50% subserosal), Type 6 (<50% subserosal), Type 7 (subserosal pedunculated), Type 8 (non-uterine). (Medical Terminology)

Colloquial Expressions

  • uterine fibroids (leiomyomas) problem
  • having uterine fibroids (leiomyomas)

ICD & ICF Classifications

icd10Code
Code pending assignment
icd10Description
FIGO Classification: Type 0 (pedunculated intracavitary), Type 1 (<50% intramural), Type 2 (≥50% intramural), Type 3 (100% intramural, touching endometrium), Type 4 (intramural only), Type 5 (≥50% subserosal), Type 6 (<50% subserosal), Type 7 (subserosal pedunculated), Type 8 (non-uterine).
icd11Code
Code pending
icd11Description
Uterine Fibroids (Leiomyomas)
icfCodes
bodyFunctions, bodyStructures, activities
snomedCtConcept
Uterine Fibroids (Leiomyomas)
meshTerms
uterine_fibroids_(leiomyomas)uterine-fibroids

Questions to Ask Your Doctor

Key Terms to Know

  • FIGO Classification: Type 0 (pedunculated intracavitary), Type 1 (<50% intramural), Type 2 (≥50% intramural), Type 3 (100% intramural, touching endometrium), Type 4 (intramural only), Type 5 (≥50% subserosal), Type 6 (<50% subserosal), Type 7 (subserosal pedunculated), Type 8 (non-uterine).
  • Benign monoclonal tumors - no malignant potential (0.1% transform to leiomyosarcoma)
  • Estrogen and progesterone dependent - grow during reproductive years, shrink after menopause
  • Multiple fibroids in 2/3 of affected women
  • Location determines symptoms more than size
  • Fibroids
  • Myomas
  • Uterine myomas

Questions to Ask Your Doctor

  • What specific tests will confirm a Uterine Fibroids (Leiomyomas) diagnosis?
  • What treatment options are most effective for my case?
  • Are there any lifestyle changes that can help manage Uterine Fibroids (Leiomyomas)?
  • What complications should I watch for with Uterine Fibroids (Leiomyomas)?
  • How does Uterine Fibroids (Leiomyomas) typically progress over time?
  • What is causing my Uterine Fibroids (Leiomyomas)?
  • Can genetic mutations be reduced or eliminated?

How to Describe Symptoms

When speaking with your doctor about Uterine Fibroids (Leiomyomas), be specific about: when symptoms first appeared, how often they occur, what makes them better or worse, and how they affect your daily life. Use a symptom diary if possible to track patterns and triggers.

Appointment Preparation

  • Write down your symptoms and when they started
  • List all medications and supplements you are taking
  • Note any family history of Uterine Fibroids (Leiomyomas) or related conditions
  • Prepare questions you want to ask your doctor
  • Bring any previous test results related to Uterine Fibroids (Leiomyomas)
  • Consider bringing a family member to your appointment

Overview

Quick 30-Second Summary

Uterine Fibroids (Leiomyomas) is are benign smooth muscle tumors of the uterus that affect up to 70-80% of women by age 50. They are the most common pelvic tumor in women and a leading cause of heavy menstrual bleeding, pelvic pressure, and reproductive dysfunction. It is characterized by benign monoclonal tumors - no malignant potential (0.1% transform to leiomyosarcoma), estrogen and progesterone dependent - grow during reproductive years, shrink after menopause, multiple fibroids in 2/3 of affected women. At Healers Clinic, our integrative approach combines evidence-based conventional medicine with homeopathy, ayurveda, and physiotherapy to address the root causes using our "Cure from the Core" philosophy. Our team of Dr. Hafeel Ambalath & Dr. Saya Pareeth and 25+ practitioners have helped 15,000+ patients find lasting relief. Book a consultation to explore how we can help you.

Prevalence

Most common benign pelvic tumor in women. Affects 70-80% of women by age 50. Higher prevalence in obese women (2-3x) and lower in smokers (paradoxically).

Severity

_symptomatic vs asymptomatic; size

Success Rate

Individual results vary based on condition severity and adherence to treatment protocols

Patients Treated

15,000+

Experience

47+ years combined integrative healthcare experience

Medical Category

FIGO Classification: Type 0

Classification

Also Known As

Fibroids, Myomas, Uterine myomas, Benign uterine tumors

ICD-10 Codes

N99 (Disorders of genitourinary system)

Treatment Options

Options

Conventional Medicine, Homeopathy, Ayurveda, Physiotherapy, Naturopathy

Constitutional HomeopathyAyurvedic ConsultationPanchakarma TherapyIntegrative PhysiotherapyNLS ScreeningNaturopathyFollow-up Consultation

Languages & Insurance

Languages Spoken

EnglishArabicHindiMalayalamUrduTagalog

Insurance Accepted

Most major insurance providers accepted - please confirm coverage at booking

Special Equipment

NLS Screening (Non-linear Bioenergetic Assessment) available

At a Glance

Key information about Uterine Fibroids (Leiomyomas) in plain language

What is Uterine Fibroids (Leiomyomas)?

Uterine fibroids (leiomyomas) are benign smooth muscle tumors of the uterus that affect up to 70-80% of women by age 50. They are the most common pelvic tumor in women and a leading cause of heavy menstrual bleeding, pelvic pressure, and reproductive dysfunction.

Who Experiences It?

Fibroids affect 70-80% of women by age 50. They are 2-3x more common in African women who also tend to develop them younger (20s vs 30s-40s in Caucasian women). Most are asymptomatic; only 25-50% cause symptoms. In the UAE, uti very common; kidney stones 10-15%

How It Develops

Fibroids grow slowly (average 1-2cm per year) but growth is unpredictable. Some remain stable for years. Rapid growth (>50% in 6 months) warrants evaluation for sarcoma. Growth accelerates during pregnancy (30% increase) due to estrogen. Postmenopausal shrinkage is typical.

Typical Symptoms

Heavy menstrual bleeding (menorrhagia), Pelvic pressure/feeling of fullness, Urinary frequency, Pelvic pain, Abdominal enlargement

Treatment Options

Conventional medications, Lifestyle modifications

General Outlook

Excellent - fibroids are benign with no malignant potential (0.1%). Symptoms improve after menopause. With appropriate treatment, most women achieve symptom relief and improved quality of life. Early diagnosis and treatment are particularly important in the UAE context where lifestyle factors are significant contributors.

Quick Statistics

Global Statistics

Global PrevalenceMost common benign pelvic tumor in women. Affects 70-80% of women by age 50. Higher prevalence in obese women (2-3x) and lower in smokers (paradoxically).
UAE PrevalenceLimited data but clinical reports suggest similar prevalence to global rates (60-70%). Higher rates reported in Emirati women compared to expatriates.
GCC PrevalenceGCC prevalence similar to global estimates. Saudi Arabia and UAE report high rates consistent with obesity and diabetes patterns in the region.

UAE & Dubai

UAE StatisticsUTI very common; kidney stones 10-15%
GCC StatisticsSimilar patterns

Risk Factors

Non-modifiable
African ancestry
Non-modifiable
Family history
Non-modifiable
Age (reproductive years)

Interesting Facts

Fibroids affect 70-80% of women by age 50 - most common pelvic tumor
Only 25-50% cause symptoms - many women don't know they have them
African ancestry is strongest risk factor - 2-3x higher rates, younger onset
Fibroids shrink after menopause - symptoms improve without treatment

Heavy menstrual bleeding Symptoms

Recognizing Uterine Fibroids (Leiomyomas) Symptoms

Common Symptoms

1
Heavy menstrual bleeding (menorrhagia)
30-50% of symptomatic fibroids

Menstrual flow >80mL per cycle; soaking pad/tampon every 1-2 hours; passing clots >1 inch.

2
Pelvic pressure/feeling of fullness
20-30%

Sensation of heaviness or pressure in lower abdomen; may notice enlarged abdomen.

3
Urinary frequency
20-30%

Increased urination frequency from bladder compression by large fibroids.

4
Pelvic pain
15-20%

Dull ache or pressure in pelvis; may worsen during menstruation.

5
Abdominal enlargement
20-30%

Visible enlargement of lower abdomen; may be mistaken for pregnancy or weight gain.

What Causes Heavy menstrual bleeding?

Risk Factors and Triggers

Primary Causes

Genetic mutations

Genetic mutations

MED12 mutation in 50-70% of fibroids. Other genes include HMGA2, FH, and COL4A5.

Hormonal factors

Hormonal factors

Estrogen and progesterone promote growth through growth factors. Progesterone inhibits apoptosis.

African ancestry

African ancestry

Unknown - possibly genetic or environmental factors. 2-3x higher rates.

Risk Factors

Non-modifiable

African ancestry

2-3x higher risk; earlier onset (20s vs 30s-40s)
Relative Risk: Strong (Level A)
Non-modifiable

Family history

2-3x increased risk with affected first-degree relative
Relative Risk: Strong (Level A)
Non-modifiable

Age (reproductive years)

Risk increases with age until menopause; peaks 40s-50s
Relative Risk: Strong (Level A)
Modifiable

Obesity (BMI >30)

2-3x increased risk; adipose estrogen production
Relative Risk: Strong (Level A)
Modifiable

Early menarche (<12 years)

1.5-2x risk due to prolonged estrogen exposure
Relative Risk: Moderate (Level B)

Types of Uterine Fibroids (Leiomyomas)

Classification

Types & Classifications

Understanding the different types and classifications

Acute Type

Sudden onset with short duration

description

Acute Uterine Fibroids (Leiomyomas) refers to the sudden onset of symptoms, typically developing rapidly over hours to days. This form often presents with more intense initial symptoms and may be triggered by specific events or exposures.

treatment

Treatment for acute Uterine Fibroids (Leiomyomas) focuses on rapid symptom relief and addressing the immediate trigger. This may include medication, lifestyle changes, and avoiding known triggers.

prognosis

With prompt and appropriate treatment, acute Uterine Fibroids (Leiomyomas) generally has a favorable prognosis. Many patients experience significant improvement or complete resolution of symptoms.

Chronic Type

Long-lasting or recurring condition

description

Chronic Uterine Fibroids (Leiomyomas) refers to a condition that persists over longer periods, typically defined as lasting more than 3-6 months. This form may develop from repeated acute episodes or have a gradual onset without resolution.

treatment

Management of chronic Uterine Fibroids (Leiomyomas) requires a comprehensive long-term approach combining conventional treatments with integrative therapies such as homeopathy, ayurveda, and physiotherapy to address underlying causes and improve quality of life.

prognosis

While chronic Uterine Fibroids (Leiomyomas) may not be fully curable, many patients achieve excellent symptom control and maintain good quality of life with appropriate ongoing management and lifestyle modifications.

Key Differences

Acute:

Sudden onset, short duration, often treatable

Chronic:

Long-lasting, may require ongoing management

Medical Disclaimer

This information is for educational purposes only. Always consult a healthcare professional for proper diagnosis and treatment of your condition.

Understanding Uterine Fibroids (Leiomyomas)

Mechanism

Pathophysiology

Understanding how this condition affects the body

1

Affected Body Systems

Primary Systems

Reproductive system (uterus, endometrium)
Urinary system (bladder, ureters from mass effect)
Gastrointestinal (rectum, sigmoid)
Hematologic (anemia from blood loss)
Cardiovascular (high output state from anemia)

The condition primarily impacts Reproductive system (uterus, endometrium), with secondary effects on other physiological networks as the body attempts to compensate for the primary dysfunction.

2

Anatomical Structures

Structures

  • Reproductive system (uterus, endometrium)
  • Urinary system (bladder, ureters from mass effect)
  • Gastrointestinal (rectum, sigmoid)
  • Hematologic (anemia from blood loss)

The key anatomical structures involved include Reproductive system (uterus, endometrium), Urinary system (bladder, ureters from mass effect), Gastrointestinal (rectum, sigmoid), where the pathological changes manifest most prominently. These structures undergo specific alterations that disrupt their normal function and contribute to the overall disease process.

3

Disease Development

The development of Uterine Fibroids (Leiomyomas) typically follows a recognizable pattern, though individual progression may vary based on underlying risk factors and timely intervention.

Stages

Initial Trigger
Variable - hours to months depending on etiology

The condition begins when an initiating factor - whether genetic predisposition, environmental trigger, infectious agent, or lifestyle factor - disrupts normal physiological balance in Reproductive system (uterus, endometrium).

Early Compensatory Changes
Days to weeks

The body activates defense mechanisms and compensatory responses to maintain function despite emerging dysfunction. Symptoms may be mild or nonspecific during this phase.

Established Disease
Weeks to months without intervention

Once compensatory mechanisms are overwhelmed, the condition reaches clinical significance with measurable physiological changes and more pronounced symptoms.

4

Progression Patterns

The condition typically follows a progression from initial trigger through compensatory phases to established disease, with potential for remission if appropriate intervention occurs early.

Variations

  • Some patients experience rapid onset with quick progression to severe symptoms
  • Others may have a gradual, insidious development over months or years
  • Individual variation depends on genetic factors, comorbidities, and lifestyle
5

Body Response

Immediate Response

The body initially responds by activating defensive mechanisms and attempting to maintain normal function through compensatory pathways, which may temporarily mask symptom severity.

Intermediate

Over time, continued strain on compensatory systems may lead to their gradual exhaustion, allowing more pronounced symptoms to emerge as the underlying pathology becomes increasingly difficult to conceal.

Long-Term

Chronic adaptations develop including structural changes in affected tissues, altered physiological set-points, and the establishment of new (often suboptimal) equilibrium states that become self-perpetuating.

6

Complications

7

Biochemical Pathways

The biochemical basis of Uterine Fibroids (Leiomyomas) involves disruption of normal metabolic and signaling pathways. Fibroids develop from a single smooth muscle cell that undergoes clonal expansion. Growth is promoted by estrogen (increasesEGF, IGF-1) and progesterone (inhibits apoptosis). Extracellular matrix (collagen) accumulates excessively. Hypoxia may promote growth as compressed vessels limit perfusion.

Primary Pathways

  • MED12 mutation in 50-70% of fibroids. Other genes include HMGA2, FH, and COL4A5.
  • Estrogen and progesterone promote growth through growth factors. Progesterone inhibits apoptosis.
  • Unknown - possibly genetic or environmental factors. 2-3x higher rates.

Secondary Pathways

  • Compensatory metabolic pathways
  • Inflammatory cascade activation
8

Genetic Factors

Familial aggregation suggests genetic component. MED12 gene mutations in 50-70% of fibroids. HMGA2 overexpression in 10%. Some hereditary syndromes (Reed syndrome - familial leiomyomatosis) associated with HLRCC gene.

Genetic Predisposition

  • Family history may increase susceptibility
  • Genetic predisposition interacts with environmental factors

Population studies show variation in prevalence across different genetic backgrounds

9

Environmental Triggers

External Factors

  • Obesity increases risk 2-3x (adipose estrogen production). Early menarche increases risk (more lifetime estrogen exposure). Vitamin D deficiency associated with higher risk. Pesticide exposure hypothesized.

Trigger Mechanisms

  • MED12 mutation in 50-70% of fibroids. Other genes include HMGA2, FH, and COL4A5.
  • Estrogen and progesterone promote growth through growth factors. Progesterone inhibits apoptosis.
  • Unknown - possibly genetic or environmental factors. 2-3x higher rates.

How is Uterine Fibroids (Leiomyomas) Diagnosed?

Diagnostic Criteria

1

Ultrasound is first-line imaging (sensitivity >95% for detecting fibroids). MRI provides superior detail for complex cases and pre-surgical planning. Hysteroscopy can evaluate submucosal fibroids directly.

Diagnostic Tests

Test NameDescriptionPurposeExpected Findings
Transvaginal ultrasound (TVUS)Transvaginal ultrasound (TVUS)
Detect and characterize fibroids; first-line imaging
Normal uterus with homogeneous myometrium
Complete blood count (CBC)Complete blood count (CBC)
Evaluate for anemia from heavy bleeding
Hgb >12 g/dL women
Pap smearPap smear
Screen for cervical abnormalities before treatment
Normal cervical cytology
Pelvic MRIPelvic MRI
Detailed fibroid mapping; pre-surgical planning
Superior to ultrasound for fibroid location and number
HysteroscopyHysteroscopy
Visualize endometrial cavity; evaluate submucosal fibroids
Direct visualization; can biopsy simultaneously
Endometrial biopsyEndometrial biopsy
Rule out endometrial hyperplasia or cancer
Required if abnormal bleeding present

Conditions to Consider

These conditions may present similarly and should be ruled out during diagnosis

Adenomyosis
Consider this condition when symptoms overlap with the primary diagnosis. Differential diagnosis helps ensure accurate identification.
Ovarian cysts/masses
Consider this condition when symptoms overlap with the primary diagnosis. Differential diagnosis helps ensure accurate identification.

Homeopathy for uterine fibroids (leiomyomas) Treatment for Uterine Fibroids (Leiomyomas)

Treatment Approaches

Treatment

Treatment Options

Comprehensive approaches to manage and treat this condition

Medications

NSAIDs (Mefenamic acid 500mg TID during period)

COX inhibition reduces prostaglandins; reduces bleeding 20-30%

NSAIDs (Mefenamic acid 500mg TID during period)

Purpose: NSAIDs (Mefenamic acid 500mg TID during period)
Potential Side Effects (1)
  • GI upset; avoid in renal impairment

Tranexamic acid 1g TID during period

Antifibrinolytic - inhibits plasmin and stabilizes clots

Tranexamic acid 1g TID during period

Purpose: Tranexamic acid 1g TID during period
Potential Side Effects (1)
  • Generally well tolerated; rare thromboembolism

Combined hormonal contraceptives (COC)

Suppresses ovulation; reduces endometrial growth; stabilizes endometrium

Combined hormonal contraceptives (COC)

Purpose: Combined hormonal contraceptives (COC)
Potential Side Effects (1)
  • Breakthrough bleeding; VTE risk; mood changes

Medical Procedures

  • Hysteroscopic myomectomy
  • Laparoscopic/robotic myomectomy
  • Uterine artery embolization (UAE/UFE)
  • Hysterectomy

Monitoring & Follow-up

  • Regular follow-up appointments
  • Symptom tracking
  • Quality of life assessment

Preventing Uterine Fibroids (Leiomyomas)

Risk Reduction

Prevention

Steps to reduce risk and promote long-term health

Primary Prevention

Risk Reduction
  • Maintain healthy weight

Secondary Prevention

Early Detection
  • Early detection through regular monitoring and screening
  • Prompt treatment of symptoms to prevent disease progression
  • Regular follow-up care with healthcare providers
  • Strict adherence to treatment plan and medication regimen

Lifestyle Modifications

Daily Habits
  • Iron supplementation
  • Weight management

Prevention Summary

Take action today to reduce your risk

1 primary4 secondary2 lifestyle

Lifestyle Recommendations for Uterine Fibroids (Leiomyomas)

Wellness

Lifestyle recommendations

Evidence-based guidance to support your treatment and recovery

Nutrition

Dietary Recommendations

Foods to nourish your body and support healing

Meal Timing

Regular meal times, avoid late-night eating

Include
Foods to Include
Whole foods
Fruits and vegetables
Lean proteins
Activity

Exercise Recommendations

Physical activity guidelines for your recovery

Recommended Intensity

Moderate - based on condition and fitness level

Recommended
Activities to Include
Aerobic exercise 30 minutes most days
Strength training twice weekly
Flexibility exercises
Avoid
Activities to Skip
High-impact activities during acute symptoms
Excessive exercise without adequate rest
Wellness

Stress Management

Techniques to reduce stress and support healing

1

Mindfulness meditation 10-15 minutes daily

2

Deep breathing exercises

3

Yoga or gentle stretching

4

Spending time in nature

Rest

Sleep Hygiene

Quality sleep essential for recovery and healing

Maintain consistent sleep schedule

Create a restful sleep environment

Limit screen time before bed

Avoid caffeine in the evening

Outlook for Uterine Fibroids (Leiomyomas)

Outlook

Prognosis & Outlook

Understanding the expected course and long-term outlook

Overall Prognosis

Expected Outcome

Excellent - fibroids are benign with no malignant potential (0.1%). Symptoms improve after menopause. With appropriate treatment, most women achieve symptom relief and improved quality of life.

Long-term Outlook

Long-term outlook is excellent. Most women achieve symptom control with appropriate treatment. Symptoms resolve after menopause regardless of treatment.

Disease Course
Understanding the Typical Progression

Typical Progression

With early intervention and appropriate treatment, many patients experience significant improvement. Without treatment, the condition may progress to more severe stages.

Treatment Response Timeline

Initial Phase

Timeframe: Weeks 1-4

  • Reduction in symptom intensity
  • Improved sleep quality
  • Increased energy levels
  • Better appetite and digestion

Indicators: Early response to treatment, even subtle improvements, is a positive sign.

Active Phase

Timeframe: Weeks 4-12

  • Significant symptom reduction
  • Improved functional capacity
  • Normalized laboratory values where applicable
  • Reduced medication needs (under supervision)

Indicators: Clear improvement in condition-specific symptoms and overall well-being.

Consolidation Phase

Timeframe: Months 3-6

  • Stable symptom control
  • Established healthy lifestyle habits
  • Reduced treatment frequency
  • Maintained improvements

Indicators: Sustained benefit with decreasing treatment intensity.

Factors Affecting Prognosis

Elements that influence your individual outlook

Menopausal status
Fibroid location
Access to treatment
Success Indicators
Signs of Treatment Success

Clinical Improvement

  • Symptom reduction (patient-reported outcome measures)
  • Improved objective findings on examination
  • Normalized laboratory values where applicable
  • Reduced medication requirements
  • Improved functional capacity and quality of life scores

Patient Experience

  • Ability to perform daily activities without limitation
  • Reduced pain and symptom burden
  • Improved sleep, energy, and mood
  • Confidence in self-management
  • Overall satisfaction with care and outcomes

Timeline: Clinical indicators typically show measurable improvement by weeks 6-12 of integrative treatment.

Follow-up Schedule

Initial

Every 1-2 weeks during active treatment for assessment and remedy adjustments.

Stabilization

Every 2-4 weeks as symptoms improve and treatment is refined.

Maintenance

Every 1-3 months once stable, for monitoring and preventive care.

Ongoing Monitoring

  • Regular symptom tracking and reporting
  • Periodic laboratory testing as indicated
  • Annual comprehensive health assessments
  • Seasonal check-ins during high-risk periods
Chronic Management
Living Well with Your Condition

With proper management, Uterine Fibroids (Leiomyomas) can be effectively controlled allowing normal daily activities and quality of life.

Coping Strategies

  • Understanding your triggers and avoiding them
  • Maintaining consistent treatment and follow-up
  • Prioritizing sleep, nutrition, and stress management
  • Building support network of family and healthcare providers
  • Monitoring symptoms and seeking help early for changes

Quality of Life: Most patients with well-managed Uterine Fibroids (Leiomyomas) live full, active lives with minimal limitations.

Support Resources: Healers Clinic offers ongoing support including patient education, support groups, and care coordination.

Hope & Support

"With advances in integrative medicine and your commitment to treatment, many patients with Uterine Fibroids (Leiomyomas) achieve significant improvement and reclaimed quality of life."

Support Systems

Healers Clinic care team available between visits
Patient education materials and resources
Connect with others through support groups (where available)
Family involvement in treatment and lifestyle changes
Mental health support for coping with chronic conditions

Living well with Uterine Fibroids (Leiomyomas) is achievable. Many patients find that managing their condition leads to healthier lifestyle overall and improved well-being beyond just the primary condition.

Frequently Asked Questions

FAQ

Frequently Asked Questions

Find answers to common questions about this condition

General Questions
Symptoms & Diagnosis
Treatment Options
Integrative Medicine
Lifestyle & Self-Management
When to Seek Help
Myth vs Fact
Cost & Insurance
Doctor-Patient Communication
Prognosis & Long-Term

What is Uterine Fibroids (Leiomyomas)?

General Questions

Uterine fibroids (leiomyomas) are benign smooth muscle tumors of the uterus that affect up to 70-80% of women by age 50. They are the most common pelvic tumor in women and a leading cause of heavy menstrual bleeding, pelvic pressure, and reproductive dysfunction.

How common is Uterine Fibroids (Leiomyomas)?

General Questions

Uterine Fibroids (Leiomyomas) affects Most common benign pelvic tumor in women. Affects 70-80% of women by age 50. Higher prevalence in obese women (2-3x) and lower in smokers (paradoxically).. In the UAE, Limited data but clinical reports suggest similar prevalence to global rates (60-70%). Higher rates reported in Emirati women compared to expatriates.. Gulf regional data suggests GCC prevalence similar to global estimates. Saudi Arabia and UAE report high rates consistent with obesity and diabetes patterns in the region..

Who is most at risk for Uterine Fibroids (Leiomyomas)?

General Questions

Fibroids affect 70-80% of women by age 50. They are 2-3x more common in African women who also tend to develop them younger (20s vs 30s-40s in Caucasian women). Most are asymptomatic; only 25-50% cause symptoms.

Is Uterine Fibroids (Leiomyomas) hereditary or genetic?

General Questions

Familial aggregation suggests genetic component. MED12 gene mutations in 50-70% of fibroids. HMGA2 overexpression in 10%. Some hereditary syndromes (Reed syndrome - familial leiomyomatosis) associated with HLRCC gene.

Can Uterine Fibroids (Leiomyomas) be prevented?

General Questions

Maintain healthy weight. Secondary prevention includes regular monitoring and early intervention.

What is the long-term outlook for someone with Uterine Fibroids (Leiomyomas)?

General Questions

Long-term outlook is excellent. Most women achieve symptom control with appropriate treatment. Symptoms resolve after menopause regardless of treatment.

What are the most common symptoms of Uterine Fibroids (Leiomyomas)?

Symptoms & Diagnosis

The most common symptoms include Heavy menstrual bleeding (menorrhagia), Pelvic pressure/feeling of fullness, Urinary frequency, Pelvic pain, Abdominal enlargement. Symptoms often follow patterns related to [object Object],[object Object].

What are the warning signs or red flag symptoms of Uterine Fibroids (Leiomyomas)?

Symptoms & Diagnosis

Red flag symptoms that require immediate attention include sudden severe symptoms, difficulty breathing, chest pain, sudden weakness or numbness, high fever, or sudden vision changes. At Healers Clinic, we educate patients on recognizing these warning signs during their consultation.

How is Uterine Fibroids (Leiomyomas) diagnosed?

Symptoms & Diagnosis

Ultrasound is first-line imaging (sensitivity >95% for detecting fibroids). MRI provides superior detail for complex cases and pre-surgical planning. Hysteroscopy can evaluate submucosal fibroids directly.. Initial tests may include Transvaginal ultrasound (TVUS), Complete blood count (CBC), Pap smear. Confirmatory testing may involve Pelvic MRI and Hysteroscopy. Our diagnostic approach at Healers Clinic combines conventional diagnostics with functional medicine assessments for comprehensive evaluation.

What tests are used to confirm Uterine Fibroids (Leiomyomas)?

Symptoms & Diagnosis

Pelvic MRI: Detailed fibroid mapping; pre-surgical planning. Hysteroscopy: Visualize endometrial cavity; evaluate submucosal fibroids. Endometrial biopsy: Rule out endometrial hyperplasia or cancer. These tests help Superior to ultrasound for fibroid location and number.

What conditions share similar symptoms with Uterine Fibroids (Leiomyomas)?

Symptoms & Diagnosis

Adenomyosis: Diffuse vs focal; heavy bleeding; often more painful. Ovarian cysts/masses: Arise from ovary, not uterus; different blood supply. Accurate differentiation is essential for appropriate treatment.

Can Uterine Fibroids (Leiomyomas) be diagnosed without specific tests?

Symptoms & Diagnosis

Clinical diagnosis of Uterine Fibroids (Leiomyomas) often relies on characteristic symptom patterns and physical findings. The diagnostic criteria include Ultrasound is first-line imaging (sensitivity >95% for detecting fibroids). MRI provides superior detail for complex cases and pre-surgical planning. Hysteroscopy can evaluate submucosal fibroids d....... At Healers Clinic, our practitioners take comprehensive histories and perform thorough examinations to establish diagnosis.

What are the first-line treatments for Uterine Fibroids (Leiomyomas)?

Treatment Options

NSAIDs (Mefenamic acid 500mg TID during period) (COX inhibition reduces prostaglandins; reduces bleeding 20-30%). Tranexamic acid 1g TID during period (Antifibrinolytic - inhibits plasmin and stabilizes clots). Combined hormonal contraceptives (COC) (Suppresses ovulation; reduces endometrial growth; stabilizes endometrium). Efficacy varies based on individual factors.

What second-line treatments are available for Uterine Fibroids (Leiomyomas)?

Treatment Options

Levonorgestrel-releasing IUD (Mirena 52mg): Women desiring contraception with heavy bleeding. GnRH agonist (Leuprolide 3.75mg monthly): Pre-surgical shrink; perimenopausal symptoms. Ulipristal acetate 5mg/day: Pre-surgical or prolonged treatment (up to 4 months).

Is surgery ever required for Uterine Fibroids (Leiomyomas)?

Treatment Options

Hysteroscopic myomectomy: Submucosal fibroids causing bleeding. Laparoscopic/robotic myomectomy: Subserosal or intramural fibroids; desire for uterine preservation.

How effective are medications for Uterine Fibroids (Leiomyomas)?

Treatment Options

Reduces bleeding 20-30%; pain relief

What are the common side effects of Uterine Fibroids (Leiomyomas) medications?

Treatment Options

GI upset; avoid in renal impairment

How long does it take for Uterine Fibroids (Leiomyomas) treatment to show results?

Treatment Options

Response time varies based on condition severity, treatment type, and individual factors. Some patients notice improvement within days to weeks, while others may require several months for optimal results. Significant and lasting improvement typically occurs over 4-12 weeks with consistent treatment. Healers Clinic provides regular progress assessments to ensure optimal timing of treatment adjustments.

Can I stop taking medication once symptoms improve?

Treatment Options

Treatment discontinuation should only occur under medical supervision. Uterine Fibroids (Leiomyomas) often requires ongoing management to prevent recurrence or worsening of symptoms. Recurrence risk is notable without continued management. Your Healers Clinic practitioner will develop an appropriate maintenance plan tailored to your individual needs and progress.

How does Healers Clinic approach Uterine Fibroids (Leiomyomas) treatment?

Integrative Medicine

Healers Clinic utilizes an integrative medicine approach combining conventional treatments with evidence-based complementary therapies. For Uterine Fibroids (Leiomyomas), this means incorporating NSAIDs (Mefenamic acid 500mg TID during period) alongside homeopathy, ayurveda, physiotherapy, and naturopathy. Our "Cure from the Core" philosophy addresses root causes rather than just symptoms for lasting healing.

Can homeopathy help treat Uterine Fibroids (Leiomyomas)?

Integrative Medicine

Homeopathy offers a gentle, individualized approach to managing Uterine Fibroids (Leiomyomas) by addressing the person's overall constitution and symptom pattern. While individual responses vary, many patients at Healers Clinic benefit from constitutional homeopathic treatment as part of their integrative care plan.

What ayurvedic treatments are used for Uterine Fibroids (Leiomyomas)?

Integrative Medicine

Ayurveda approaches Uterine Fibroids (Leiomyomas) through dietary modifications, herbal preparations, and detoxification procedures like Panchakarma. Healers Clinic incorporates evidence-based ayurvedic treatments alongside conventional care for comprehensive management.

Can physiotherapy help with Uterine Fibroids (Leiomyomas)?

Integrative Medicine

Physiotherapy can be highly beneficial for Uterine Fibroids (Leiomyomas), particularly when musculoskeletal components are involved. Healers Clinic's integrative physiotherapists use targeted exercises, manual therapy, and modalities to reduce pain, improve function, and support recovery.

Is naturopathy recommended for Uterine Fibroids (Leiomyomas)?

Integrative Medicine

Naturopathy offers valuable support for Uterine Fibroids (Leiomyomas) through natural therapies, nutritional counseling, and lifestyle modifications. Healers Clinic's naturopathic practitioners work with conventional treatments to provide holistic care that supports the body's natural healing processes.

How do you combine conventional and complementary treatments for Uterine Fibroids (Leiomyomas)?

Integrative Medicine

At Healers Clinic, we carefully integrate conventional medicine with complementary therapies based on each patient's unique needs. For Uterine Fibroids (Leiomyomas), this means using NSAIDs (Mefenamic acid 500mg TID during period) as appropriate while incorporating supportive therapies such as homeopathy, ayurveda, and physiotherapy. This integrative approach minimizes side effects, enhances treatment efficacy, and addresses root causes for sustainable improvement.

Are there any interactions between homeopathic and conventional treatments for Uterine Fibroids (Leiomyomas)?

Integrative Medicine

Generally, homeopathic remedies can be safely used alongside conventional treatments for Uterine Fibroids (Leiomyomas) when prescribed by qualified practitioners. At Healers Clinic, our homeopathic and conventional practitioners work together to ensure safe, coordinated care. We carefully select remedies and timing to avoid any potential interactions while maximizing therapeutic benefit.

What dietary changes help manage Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Dietary management of Uterine Fibroids (Leiomyomas) typically includes anti-inflammatory foods, reduced processed sugar, increased fiber intake. Healers Clinic's nutritionists provide personalized dietary guidance based on your condition and constitution.

What lifestyle modifications help with Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Iron supplementation (Correct and prevent iron deficiency anemia). Weight management (May reduce estrogen and slow fibroid growth).

Can exercise help Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Uterine Fibroids (Leiomyomas) often benefits from regular exercise. Exercise helps improve circulation, reduce stress, and support overall health. Healers Clinic physiotherapists design safe, effective exercise programs tailored to your condition and fitness level.

How does stress affect Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Stress can significantly impact Uterine Fibroids (Leiomyomas) by exacerbating symptoms and interfering with treatment efficacy. The condition's mechanism involves Fibroids develop from a single smooth muscle cell that undergoes clonal expansion. Growth is promote... Healers Clinic incorporates stress management techniques including mindfulness, yoga, and relaxation therapies into treatment plans.

What sleep hygiene practices benefit Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Quality sleep is essential for healing and symptom management in Uterine Fibroids (Leiomyomas). Recommended practices include maintaining consistent sleep schedules, creating restful environments, limiting screen time before bed, and avoiding caffeine close to bedtime. Poor sleep can worsen pain, fatigue, and cognitive symptoms. Healers Clinic addresses sleep as a foundational aspect of health.

Are there any triggers to avoid with Uterine Fibroids (Leiomyomas)?

Lifestyle & Self-Management

Uterine Fibroids (Leiomyomas) triggers vary by individual, but common exacerbating factors include stress, poor sleep, processed foods. Environmental factors such as Obesity increases risk 2-3x (adipose estrogen production). Early menarche increases risk (more lifetime estrogen exposure). Vitamin D deficiency associated with higher risk. Pesticide exposure hypothesized. may also play a role. Healers Clinic helps identify personal triggers through detailed history-taking and symptom tracking.

When should I seek emergency care for Uterine Fibroids (Leiomyomas)?

When to Seek Help

Seek immediate emergency care if you experience [object Object], [object Object].

How do I know if my Uterine Fibroids (Leiomyomas) symptoms require urgent care?

When to Seek Help

Urgent care is recommended for [object Object], [object Object].

Should I get a second opinion for Uterine Fibroids (Leiomyomas)?

When to Seek Help

A second opinion can be valuable for Uterine Fibroids (Leiomyomas), especially if diagnosis is unclear, treatment has been unsuccessful, or symptoms are progressive. Healers Clinic welcomes patients seeking second opinions and offers comprehensive reassessments using both conventional and functional medicine approaches to ensure accurate diagnosis and optimal treatment planning.

How often should I follow up for Uterine Fibroids (Leiomyomas) management?

When to Seek Help

Regular follow-up is essential for Uterine Fibroids (Leiomyomas) management. Healers Clinic typically recommends initial visits every 2-4 weeks during active treatment, transitioning to monthly or quarterly visits as symptoms stabilize.

Is Uterine Fibroids (Leiomyomas) just a part of normal aging?

Myth vs Fact

Uterine Fibroids (Leiomyomas) is not necessarily an inevitable part of aging. As a FIGO Classification: Type 0 (pedunculated intracavitary), Type 1 (<50% intramural), Type 2 (≥50% intramural), Type 3 (100% intramural, touching endometrium), Type 4 (intramural only), Type 5 (≥50% subserosal), Type 6 (<50% subserosal), Type 7 (subserosal pedunculated), Type 8 (non-uterine)., it requires proper evaluation and management. Healers Clinic helps patients of all ages achieve optimal function through targeted treatment.

Can Uterine Fibroids (Leiomyomas) be cured with lifestyle changes alone?

Myth vs Fact

Uterine Fibroids (Leiomyomas) management typically requires integrated approaches combining lifestyle modifications with appropriate medical intervention. Addressing modifiable risk factors such as Obesity (BMI >30) and Early menarche (<12 years) is crucial. Healers Clinic's integrative approach combines lifestyle medicine with conventional and complementary treatments.

Is Uterine Fibroids (Leiomyomas) contagious?

Myth vs Fact

Uterine Fibroids (Leiomyomas) is not contagious in the traditional sense. It cannot be transmitted through casual contact. Healers Clinic can help determine if infectious factors are involved in your case.

Do I need to see a specialist for Uterine Fibroids (Leiomyomas) or can a general doctor manage it?

Myth vs Fact

While primary care physicians can diagnose and manage Uterine Fibroids (Leiomyomas), the complex nature of the condition often benefits from specialized care. Healers Clinic offers integrative medicine specialists who combine conventional expertise with complementary therapies for comprehensive management that addresses all aspects of your health.

Is medication for Uterine Fibroids (Leiomyomas) safe for long-term use?

Myth vs Fact

Long-term medication safety for Uterine Fibroids (Leiomyomas) depends on the specific treatment, dosage, and individual factors. Side effects such as GI upset; avoid in renal impairment Healers Clinic periodically reassesses medication necessity and explores opportunities to minimize pharmaceutical intervention through integrative approaches.

Does Uterine Fibroids (Leiomyomas) only affect older adults?

Myth vs Fact

Uterine Fibroids (Leiomyomas) typically affects adults but can occur at various ages. In the UAE, cases are seen across age groups. Healers Clinic provides age-appropriate care for all patients, from children to seniors.

Can alternative medicine alone treat Uterine Fibroids (Leiomyomas)?

Myth vs Fact

While complementary and alternative medicine approaches can significantly support Uterine Fibroids (Leiomyomas) management, relying solely on alternative treatments without proper medical evaluation may not be optimal. Healers Clinic's integrative approach combines the best of conventional medicine with evidence-based complementary therapies for comprehensive care that prioritizes patient safety and outcomes.

Is treatment for Uterine Fibroids (Leiomyomas) covered by insurance?

Cost & Insurance

Many insurance providers cover consultations and treatments related to Uterine Fibroids (Leiomyomas). Healers Clinic accepts most major insurance plans. Coverage may vary for different treatment modalities. We recommend contacting our office with your insurance information to verify coverage specifics for your treatment plan.

What are the costs of integrative treatment for Uterine Fibroids (Leiomyomas) at Healers Clinic?

Cost & Insurance

Treatment costs vary based on the specific treatments recommended for your Uterine Fibroids (Leiomyomas). Initial consultations at Healers Clinic involve comprehensive assessment to develop a personalized treatment plan. We provide transparent cost estimates before beginning treatment and offer flexible payment options. Contact us for specific pricing information.

Are homeopathic and ayurvedic treatments for Uterine Fibroids (Leiomyomas) covered by insurance?

Cost & Insurance

Insurance coverage for complementary treatments varies by provider and plan. Some insurers cover these modalities when provided by licensed practitioners. Healers Clinic's staff can assist you in understanding your coverage and exploring all available options for making treatment affordable.

How can I reduce costs while getting effective Uterine Fibroids (Leiomyomas) treatment?

Cost & Insurance

Cost reduction strategies for Uterine Fibroids (Leiomyomas) treatment include utilizing generic medications when appropriate, focusing on lifestyle modifications that reduce medication needs, scheduling regular follow-ups to prevent complications, and exploring package deals for multiple treatment modalities. Healers Clinic works with patients to create cost-effective treatment plans without compromising care quality.

What should I tell my Healers Clinic practitioner about my Uterine Fibroids (Leiomyomas)?

Doctor-Patient Communication

Share complete information about your Uterine Fibroids (Leiomyomas) symptoms including when they started, what triggers or relieves them, how they affect your daily life, all medications and supplements you're taking, previous treatments you've tried, and any concerns or questions you have. The more information your practitioner has, the better they can tailor your treatment plan.

How do I prepare for my first appointment for Uterine Fibroids (Leiomyomas)?

Doctor-Patient Communication

To prepare: gather medical records and list of current medications, write down your symptoms and their patterns, note any questions you have, be ready to discuss your medical history and family history, and consider bringing a family member for support. Healers Clinic's initial consultations are comprehensive and may take 60-90 minutes.

How can I get the most out of my Uterine Fibroids (Leiomyomas) treatment?

Doctor-Patient Communication

Maximize treatment benefit by following your personalized treatment plan consistently, attending all scheduled follow-up appointments, communicating openly about what's working and what isn't, implementing lifestyle modifications as recommended, keeping a symptom diary to track progress, and being patient as healing takes time. Healers Clinic's team approach ensures continuous support.

Can I contact my practitioner between appointments if Uterine Fibroids (Leiomyomas) worsens?

Doctor-Patient Communication

Healers Clinic understands that symptoms may change between appointments. Our office provides guidance on when and how to reach out for concerns. For urgent issues during treatment, contact our office directly. If you experience emergency symptoms, seek immediate emergency care before contacting our office.

How does Healers Clinic involve patients in Uterine Fibroids (Leiomyomas) treatment decisions?

Doctor-Patient Communication

At Healers Clinic, we believe in shared decision-making for Uterine Fibroids (Leiomyomas) management. Your practitioner will explain all treatment options, discuss benefits and risks, consider your preferences and values, and together develop a treatment plan that aligns with your health goals. Patient education and involvement are central to our "Cure from the Core" approach.

What is the prognosis for someone with Uterine Fibroids (Leiomyomas)?

Prognosis & Long-Term

Excellent - fibroids are benign with no malignant potential (0.1%). Symptoms improve after menopause. With appropriate treatment, most women achieve symptom relief and improved quality of life.

Will Uterine Fibroids (Leiomyomas) recur after treatment?

Prognosis & Long-Term

New fibroids can develop after myomectomy (10-30% recurrence at 5 years). UFE has 20-30% recurrence requiring later hysterectomy.

How will Uterine Fibroids (Leiomyomas) affect my quality of life long-term?

Prognosis & Long-Term

With treatment, quality of life improves significantly. Untreated symptomatic fibroids cause chronic fatigue (anemia), activity limitation (bleeding, pain), and psychosocial impact.

Can Uterine Fibroids (Leiomyomas) lead to other health complications?

Prognosis & Long-Term

Potential complications of Uterine Fibroids (Leiomyomas) include Iron deficiency anemia (20-40% of women with heavy bleeding risk), Infertility (5-10% of infertility cases attributable to fibroids risk), Pregnancy complications (10-30% of pregnancies with fibroids have complications risk). Acute complications may include Acute hemorrhage. Early and consistent treatment at Healers Clinic helps prevent complications.

What factors improve the long-term outlook for Uterine Fibroids (Leiomyomas)?

Prognosis & Long-Term

Positive prognostic factors include Menopausal status (Postmenopausal women have shrinking fibroids and symptom resolution), Fibroid location (Submucosal cause most symptoms; subserosal often asymptomatic), Access to treatment (Timely treatment improves quality of life outcomes). Evidence level varies for each factor.

Will I need treatment for Uterine Fibroids (Leiomyomas) for life?

Prognosis & Long-Term

Uterine Fibroids (Leiomyomas) management duration depends on individual response and condition chronicity. Treatment goals include Resolve or reduce heavy bleeding, Correct anemia, Relieve pelvic pressure/bulk symptoms. Healers Clinic periodically reassesses treatment necessity and works toward minimizing intervention when appropriate.

Can children outgrow Uterine Fibroids (Leiomyomas)?

Prognosis & Long-Term

Uterine Fibroids (Leiomyomas) management varies by age group. While some conditions improve with age, proper treatment during childhood and adolescence is important for optimal outcomes.

Still have questions? Our specialists are here to help. Contact us or book a consultation.

Ready to Address Your Uterine Fibroids (Leiomyomas)?

Our integrative team is here to help you find lasting relief through our "Cure from the Core" approach

Serving patients in Dubai, UAE, and international patients welcome. Located in Jumeira 2, serving all Emirates.